EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Characteristics of Brazilian Patients with MH History

Helga C A Silva iD, Daniela C Mendonça, Brandow W Souza iD, Joilson M Santos, Lucas S Souza, Antonio F R Junior, Felipe T G R Vasconcelos, Pamela V Andrade, Acary S B Oliveira iD, Mariz Vainzof iD

Genes · 2025

DOI: 10.3390/genes16101127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Helga C A Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brazilian Malignant Hyperthermia Unit, Department of Anesthesiology, Pain and Intensive Care, Federal University of São Paulo, São Paulo 04039-032, S…. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Malignant Hyperthermia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: capes, fapesp, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Malignant hyperthermia (MH) is a pharmacogenetic hypermetabolic syndrome triggered by halogenated agents/succinylcholine. Most families present variants in the RYR1 and, rarely, in other genes (CACNA1S/STAC3/ASPH). However, each country or region presents differences in the type and frequency of MH variants.

Objective

To present the genetic characteristics of Brazilian individuals with MH history.

Methods

We reviewed clinical and laboratory data from all families referred for evaluation in the Brazilian MH unit due to a personal or family history of MH during anesthesia. Demographic and clinical data were collected, as well as serum creatine kinase (CK) levels, in vitro contracture test (IVCT) results, and the results of anatomopathological studies of skeletal muscle. Molecular analysis was performed using whole-exome sequencing (WES). Patients with and without variants were compared.

Results

WES analysis was available for 61 patients (29 patients who survived an MH crisis and 32 relatives). Variants in the RYR1 were found in 38 patients (62.2%), and no variants were identified in 20 patients (32.7%). More than one variant in the RYR1 was found in six individuals. Variants in the CACNA1S were found in three patients (4.9%), all of them with concomitant variants in the RYR1. Three patients presented variants in the STAC3 (4.9%). Comparing the groups of patients with variants in the RYR1 with the one with no variants in this gene, it was observed that the first group showed higher levels of serum CK, a greater frequency of ptosis, strabismus, and cores, and a higher amplitude of contracture in the IVCT after caffeine or halothane.

Conclusion

In this preliminary evaluation of Brazilian individuals with MH history, the frequency of RYR1 variants was similar to those of previous reports in other countries, but there was a higher frequency of STAC3 and CACNA1S variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ryanodine Receptor Calcium Release ChannelMalignant HyperthermiaHumansBrazilMaleFemaleAdultChildAdolescentExome SequencingYoung AdultMutationCalcium Channels, L-TypeChild, PreschoolMiddle Aged

Stichwörter der Autor:innen

malignant hyperthermiamyopathyryanodine receptor calcium release channel

Substanzen

Ryanodine Receptor Calcium Release ChannelRYR1 protein, humanCACNA1S protein, humanCalcium Channels, L-Type

Autor:innen und Institutionen

  • Brazilian Malignant Hyperthermia Unit, Department of Anesthesiology, Pain and Intensive Care, Federal University of São Paulo, São Paulo 04039-032, SP, Brazil.
  • Human Genome and Stem Cells Research Center, Institute of Biosciences, University of São Paulo, São Paulo 05508-090, SP, Brazil.
  • Department of Neurology, Federal University of São Paulo, São Paulo 040039-032, SP, Brazil.

ORCID-Profile: Helga C A Silva, Brandow W Souza, Acary S B Oliveira, Mariz Vainzof

Förderung

  • capes
  • fapesp
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo—Centro de Pesquisa, Inovação e Difusão
  • Conselho Nacional de Desenvolvimento Cientıfico e Tecnológico
  • Financiadora de Estudos e Projetos (FINEP)
  • CAPES—Coordenação de aperfeiçoamento de Pessoal de Nivel Superior

Zitieren

APA

Silva, H. C. A., Mendonça, D. C., Souza, B. W., Santos, J. M., Souza, L. S., Junior, A. F. R., Vasconcelos, F. T. G. R., Andrade, P. V., Oliveira, A. S. B., & Vainzof, M. (2025). Genetic Characteristics of Brazilian Patients with MH History. Genes. https://doi.org/10.3390/genes16101127

Vancouver

Silva HCA, Mendonça DC, Souza BW, Santos JM, Souza LS, Junior AFR, et al. Genetic Characteristics of Brazilian Patients with MH History. Genes. 2025. doi:10.3390/genes16101127

BibTeX
@article{Silva2025,
  author = {Silva, Helga C A and Mendonça, Daniela C and Souza, Brandow W and Santos, Joilson M and Souza, Lucas S and Junior, Antonio F R and Vasconcelos, Felipe T G R and Andrade, Pamela V and Oliveira, Acary S B and Vainzof, Mariz},
  title = {Genetic Characteristics of Brazilian Patients with MH History},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16101127}
}
Kostenlos starten →